With sales of its lone product in a precipitous decline in the United States, Amarin has turned to an experienced local ...

The ovarian cancer market has transformed in recent years, driven by the expanding use of PARP inhibitors, antiangiogenic ...

Pfizer PFE is one of the largest and most successful drugmakers in oncology.It boasts a strong portfolio of approved cancer medicines as well as a robust pipeline of cancer candidates with a focus ...

The new data comes shortly after Imfinzi was approved as a peri-operative treatment for muscle-invasive bladder cancer (MIBC), based on the results of the NIAGARA trial, ...

AZ taps Chinese firm CSPC's AI acumen in $5.2bn+ alliance. AstraZeneca taps China's CSPC Pharma for new drug candidates a second time – and the latest AI-focused alliance is a big one.

Reuters.com is your online source for the latest Europe news stories and current events, ensuring our readers up to date with any breaking news developments ...

IMFINZI® (durvalumab) regimen reduced risk of progression, recurrence or death by 29% in early-stage gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial Business Wire Jun 1, 2025 ...

Donald Trump needled France Tuesday saying 'you would be speaking German right now' had it not been for the U.S.'s involvement in World War II, as he again touted Saturday's Army parade. 919 comment s ...